BR9606603A - Formulação de ciclosporina dispersão aquosa de nanopartículas de ciclosporina kit e processo de preparação de dispersão aquosa de partículas de ciclosporina - Google Patents

Formulação de ciclosporina dispersão aquosa de nanopartículas de ciclosporina kit e processo de preparação de dispersão aquosa de partículas de ciclosporina

Info

Publication number
BR9606603A
BR9606603A BR9606603A BR9606603A BR9606603A BR 9606603 A BR9606603 A BR 9606603A BR 9606603 A BR9606603 A BR 9606603A BR 9606603 A BR9606603 A BR 9606603A BR 9606603 A BR9606603 A BR 9606603A
Authority
BR
Brazil
Prior art keywords
cyclosporine
aqueous dispersion
nanoparticles
kit
formulation
Prior art date
Application number
BR9606603A
Other languages
English (en)
Inventor
Moo J Cho
Ralph E Levy
Philippe J Pouletty
H Robert Floc
Christian Merle
Original Assignee
Sangstat Medical Corp
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/519,689 external-priority patent/US5834017A/en
Priority claimed from US08/620,021 external-priority patent/US5766629A/en
Priority claimed from US08/622,516 external-priority patent/US5827822A/en
Application filed by Sangstat Medical Corp, Univ North Carolina filed Critical Sangstat Medical Corp
Publication of BR9606603A publication Critical patent/BR9606603A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
BR9606603A 1995-08-25 1996-07-31 Formulação de ciclosporina dispersão aquosa de nanopartículas de ciclosporina kit e processo de preparação de dispersão aquosa de partículas de ciclosporina BR9606603A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/519,689 US5834017A (en) 1995-08-25 1995-08-25 Oral cyclopsporin formulations
US08/620,021 US5766629A (en) 1995-08-25 1996-03-21 Oral cyclosporin formulations
US08/622,516 US5827822A (en) 1996-03-25 1996-03-25 Cyclosporin a formulations as nanoparticles
PCT/US1996/012569 WO1997007787A1 (en) 1995-08-25 1996-07-31 Oral cyclosporin formulations

Publications (1)

Publication Number Publication Date
BR9606603A true BR9606603A (pt) 1997-09-30

Family

ID=27414735

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606603A BR9606603A (pt) 1995-08-25 1996-07-31 Formulação de ciclosporina dispersão aquosa de nanopartículas de ciclosporina kit e processo de preparação de dispersão aquosa de partículas de ciclosporina

Country Status (27)

Country Link
EP (1) EP0789561B1 (pt)
JP (1) JP3009742B2 (pt)
KR (1) KR100294935B1 (pt)
CN (1) CN1164828A (pt)
AR (1) AR001985A1 (pt)
AT (1) ATE263550T1 (pt)
AU (1) AU709548B2 (pt)
BG (1) BG62875B1 (pt)
BR (1) BR9606603A (pt)
CA (1) CA2202887A1 (pt)
CZ (1) CZ124897A3 (pt)
DE (2) DE69632125T2 (pt)
ES (1) ES2129381T1 (pt)
GE (1) GEP20012547B (pt)
HK (1) HK1001956A1 (pt)
HU (1) HUP9801052A3 (pt)
IL (1) IL120673A0 (pt)
IS (1) IS4460A (pt)
MX (1) MX9702809A (pt)
NO (1) NO971890D0 (pt)
NZ (1) NZ313899A (pt)
PL (1) PL319898A1 (pt)
RO (1) RO119815B1 (pt)
SI (1) SI9620014A (pt)
SK (1) SK53697A3 (pt)
TW (1) TW460287B (pt)
WO (1) WO1997007787A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
US6657104B1 (en) 1997-10-16 2003-12-02 Texas Systems, University Of The Board Of The Regents Transgenic mouse model for cardiac hypertrophy and methods of use thereof
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
EP2586428B1 (en) 2007-04-26 2023-11-08 Sublimity Therapeutics Limited Manufacture of multiple minicapsules
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
GB2485327A (en) 2009-08-12 2012-05-09 Sigmoid Pharma Ltd Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물
CN104940132B (zh) * 2015-06-05 2018-02-27 河南牧翔动物药业有限公司 一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
ES2168271T3 (es) * 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
CA2231404C (en) * 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them

Also Published As

Publication number Publication date
JPH10509462A (ja) 1998-09-14
BG62875B1 (bg) 2000-10-31
NZ313899A (en) 2000-03-27
EP0789561A1 (en) 1997-08-20
CA2202887A1 (en) 1997-03-06
KR100294935B1 (ko) 2001-07-12
WO1997007787A1 (en) 1997-03-06
RO119815B1 (ro) 2005-04-29
PL319898A1 (en) 1997-09-01
EP0789561A4 (en) 1998-12-02
JP3009742B2 (ja) 2000-02-14
IL120673A0 (en) 1997-08-14
MX9702809A (es) 1998-02-28
BG101443A (en) 1998-03-31
KR970706803A (ko) 1997-12-01
CZ124897A3 (en) 1997-09-17
ATE263550T1 (de) 2004-04-15
CN1164828A (zh) 1997-11-12
DE69632125D1 (de) 2004-05-13
HK1001956A1 (en) 1998-07-24
DE69632125T2 (de) 2004-09-16
DE789561T1 (de) 1999-06-10
AU709548B2 (en) 1999-09-02
ES2129381T1 (es) 1999-06-16
HUP9801052A3 (en) 1998-12-28
IS4460A (is) 1997-04-08
NO971890L (no) 1997-04-24
EP0789561B1 (en) 2004-04-07
HUP9801052A2 (hu) 1998-09-28
GEP20012547B (en) 2001-10-25
NO971890D0 (no) 1997-04-24
SI9620014A (sl) 1998-04-30
SK53697A3 (en) 1997-10-08
AR001985A1 (es) 1998-01-07
AU6644196A (en) 1997-03-19
TW460287B (en) 2001-10-21

Similar Documents

Publication Publication Date Title
BR9606603A (pt) Formulação de ciclosporina dispersão aquosa de nanopartículas de ciclosporina kit e processo de preparação de dispersão aquosa de partículas de ciclosporina
AU6675398A (en) Aqueous dispersion of hydrophobic particles and films produced thereby
AU7681296A (en) Dispersion of plant pulp in concrete and use thereof
AU7668598A (en) The optical detection and analysis of sub-micron particles
BR9600926A (pt) Micelas mistas composições aquosas processo para a preparação de micelas mistas e uso
BR9611251A (pt) Composição pulverulenta redispersível em água processo de preparação da mesma pseudo-látex e utilização do mesmo
DE60130817D1 (de) Dispersion von Siliciumdioxid-Partikelagglomeraten und Verfahren zu ihrer Herstellung
BR9506204A (pt) Dispersão aquosa de poliuretanos contendo ligações siloxano produção da mesma e uso em composiçoes de revestimento
DE69720833T2 (de) Wässrige Suspension von kompositen Teilchen und Verfahren zu ihrer Herstellung
BR9505809A (pt) Composição compreendendo um pigmento oticamente variável processo para produção de partículas de pigmento oticamente variável modificado e composição de revestimento aquosa
DE69832124D1 (de) Wässrige Suspension von dispergierten anorganischen Partikeln und Herstellungsverfahren
AU2002309891A1 (en) Method of using optically-activated particles in cosmetic preparations
BR9608376A (pt) Utilização em cosméticos de uma composição sólida expandida composição de uso cosmético ou dermatológico processo de preparação de uma composição e utilização de composição
BR9601404A (pt) Composição de limpeza e condicionamento combinados e processo de limpeza e condicionamento concomitantes da pele ou dos cabelos
DE69840410D1 (de) Verfahren zum dispergieren von unlöslichen substanzen in wässrigen lösungen und landwirtschaftliche formulierungen
IT1282797B1 (it) Pirril-(indolil)-aril-sulfoni e relativo processo di produzione ed impiego nella terapia delle infezioni da virus dell'aids
AU8379398A (en) Nanocrystal dispersed amorphous alloys and method of preparation thereof
DE69936077D1 (de) Feines hydrophobes Titanoxidpulver und Verfahren zu seiner Herstellung
AU7739396A (en) Flow cytometric pharmacosensitivity assay and method of cancer treatment
AU4775797A (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
DE69518717D1 (de) Verfahren zur Dispergierung von Pigmenten und wässrige Pigmentdispersion
AU2204300A (en) Gas-purged ionizers and methods of achieving static neutralization thereof
BR9500884A (pt) Composições cosméticas de uso tópico processo de preparação de composições utilização de composições e processo de tratamento cosmético
ITMI962476A0 (it) Agente polimerico per la filtrazione degli ultravioletti e processo per la sua preparazione
AU4992299A (en) Uncoupling protein 4 (ucp-4) and methods of use

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SUSPENSAO DO ANDAMENTO DO PEDIDO DE PATENTE, PARA QUE SEJA COMPLEMENTADA A RETRIBUICAO EQUIVALENTE AO PEDIDO DE EXAME DE 27 (VINTE E SETE) REIVINDICACOES, VISTO QUE A RETRIBUICAO PAGA ATRAVES DA PETICAO N RJ 023062, DE 19971009, REFERE-SE A 14 (QUATORZE) REIVINDICACOES SOMENTE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1861 DE 05/09/2006.